EUVIMEDEUVIMED entdecken
Crossref

Evaluation of Efficacy, Safety and Patients' Satisfaction of Therapeutic Switch from Off-Label Swallowed Topical Corticosteroids to Budesonide Orodispersible Tablets in patients with Eosinophilic Esophagitis

G. Pellegatta, E. Mastrorocco, F. Racca, F. Giugliano, M. Spadaccini, R. Maselli, A. Fugazza, C. Hassan, A. Repici

Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S427

DOI: 10.1055/s-0044-1783772 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von G. Pellegatta und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Swallowed Topical Steroids (STCs) have been used off-label for eosinophilic esophagitis (EoE) treatment. Recently a new designed formulation of budesonide orodispersible tablet (BOT) has been specifically approved as EoE official therapy. The aim of our study was to evaluate efficacy, safety and patients’ satisfaction of therapeutic switch from off-label STCs to BOT (NCT05594849).

Methods

Endoscopic and histologic evaluation was performed under STCs and 12-16 weeks after switching to BO. Moreover, before and after switch, specific questionnaires were used to assess severity of symptoms (DSS, DSQ), quality of life (EoE-QoL) and satisfaction of the treatment (19 items from 0 to 4 about modality of assumption, taste and perception of safety).

Results

Thirty-one EoE patients, PPI non responders, receiving off-label STCs (74.2% fluticasone, 25.8% budesonide), were enrolled. Endoscopy data were available in 28 patients (90.3%). Before the switch, 10/28 patients (35.7%) showed active disease (>15 EOS/HPF), 2/28 (7.1%) were in histologic remission (

Zitieren

APA

Pellegatta, G., Mastrorocco, E., Racca, F., Giugliano, F., Spadaccini, M., Maselli, R., Fugazza, A., Hassan, C., & Repici, A. (2024). Evaluation of Efficacy, Safety and Patients' Satisfaction of Therapeutic Switch from Off-Label Swallowed Topical Corticosteroids to Budesonide Orodispersible Tablets in patients with Eosinophilic Esophagitis. Endoscopy, 56(S 02 S 02), S427. https://doi.org/10.1055/s-0044-1783772

Vancouver

Pellegatta G, Mastrorocco E, Racca F, Giugliano F, Spadaccini M, Maselli R, et al. Evaluation of Efficacy, Safety and Patients' Satisfaction of Therapeutic Switch from Off-Label Swallowed Topical Corticosteroids to Budesonide Orodispersible Tablets in patients with Eosinophilic Esophagitis. Endoscopy. 2024;56(S 02 S 02):S427. doi:10.1055/s-0044-1783772

BibTeX
@article{Pellegatta2024,
  author = {Pellegatta, G. and Mastrorocco, E. and Racca, F. and Giugliano, F. and Spadaccini, M. and Maselli, R. and Fugazza, A. and Hassan, C. and Repici, A.},
  title = {Evaluation of Efficacy, Safety and Patients' Satisfaction of Therapeutic Switch from Off-Label Swallowed Topical Corticosteroids to Budesonide Orodispersible Tablets in patients with Eosinophilic Esophagitis},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {S 02 S 02},
  pages = {S427},
  doi = {10.1055/s-0044-1783772}
}
Kostenlos starten →